Skip to main content
Clinical Trials/NCT03474406
NCT03474406
Completed
Not Applicable

The Effectiveness of Cancer Pain Management Including Early Pain Intervention, Early Multi Modality Treatment and Closed Follow up in Siriraj Outpatient Pain Clinic

Mahidol University1 site in 1 country150 target enrollmentJanuary 3, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pain, Chronic
Sponsor
Mahidol University
Enrollment
150
Locations
1
Primary Endpoint
Improvement of Pain.
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

-Background: Cancer is one of the most common cause of death. Cancer pain is often cited as one of the most feared in cancer patients. Although, WHO guidelines have been provided to improve pain outcome, the results are still unsatisfied. In order to improve cancer pain management we consider to contribute a new guideline which includes interdisciplinary approach, early doing the pain interventions, breakthrough pain, education, high quality of pain assessment and contribute the effectiveness follow-up system

Detailed Description

* Objectives:Primary outcome is study the effectiveness of new approach and closed follow up system by relief pain intensity 30% at 3 month up to 80% of all new cancer pain patients in OPD setting Secondary outcomes are quality of life (BPI,ESAS), side effect of treatments and the contributing factors that impact on the outcomes * Study design:A prospective observational study * Sample size : 150 * Data collection: General information: age, gender, body weight, height, religion, residence, care giver, occupation, income, education, medical problem Clinical pain information: primary diagnosis, staging, cancer site, current medications Clinical assessment: at three study time points: baseline (initial assessment) and the three subsequent follow-ups (FU1, FU2 and FU3)

Registry
clinicaltrials.gov
Start Date
January 3, 2018
End Date
June 30, 2019
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Cancer pain patients
  • more than 18 years old

Exclusion Criteria

  • Clinical instability
  • Cannot read and write
  • Do not know the diagnosis

Outcomes

Primary Outcomes

Improvement of Pain.

Time Frame: Approximately 12 wks from the baseline

Numerical Pain Rating Scale Total score 0-10 (0 is best outcome, 10 is worst outcome) 0-3 is mild pain, 4-7 is moderate pain, 7-10 is severe pain.

Secondary Outcomes

  • Total Brief Pain Inventory (BPI)(Approximately 12 wks from the baseline)
  • Edmonton Symptom Assessment System(ESAS)(Approximately 12 wks from the baseline)
  • Percentage of Moderate to Severe Sedation(Approximately 12 wks from the baseline.)
  • Percentage of Moderate to Severe Neausea and Vomitting(Approximately 12 wks from the baseline)
  • Percentage of Moderate to Severe Constipation(Approximately 12 wks from the baseline)
  • Percentage of Satisfied With the Service (Score=3)(Approximately 12 wks from the baseline.)

Study Sites (1)

Loading locations...

Similar Trials